Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The peroxisomal beta-oxidation pathway is a catabolic process within peroxisomes, primarily responsible for the breakdown of very long-chain fatty acids (VLCFAs), branched-chain fatty acids, and certain lipid molecules. It shortens these fatty acid chains for further degradation in mitochondria or utilization in other metabolic pathways. Key enzymes include Acyl-CoA Oxidase (AOX), Peroxisomal Bifunctional Enzyme (PBE), and Thiolase. The pathway generates acetyl-CoA and hydrogen peroxide (H₂O₂), which is decomposed by catalase. Defects lead to accumulation of VLCFAs or branched-chain lipids, contributing to disorders like X-linked adrenoleukodystrophy or Zellweger spectrum disorders. The pathway is inducible by PPARα ligands.
Activation of PPARα, modulation of fatty acid metabolism
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peroxisomal Beta-Oxidation Pathway.